Real-world treatment patterns and clinical outcomes in relapsed/refractory multiple myeloma across Asia: a multicenter Asian Myeloma Network study (AMN010) - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Treatment Approaches and Clinical Outcomes for Relapsed/Refractory Multiple Myeloma in Asia: A Multicenter Asian Myeloma Network Study (AMN010)

  • By

  • Melinda SY Tan

  • Kye Ling Wong

  • Cinnie Soekojo

  • Chandramouli Nagarajan

  • Sarah Burkhill

  • Xinhua Li

  • Ho-Jin Shin

  • Jong Heon Jung

  • Yeung-Chul Mun

  • Ho-Young Yhim

  • Jae Hoon Lee

  • Ling Cao

  • Tadao Ishida

  • Chihiro Shimazaki

  • Makoto Sasaki

  • Hiroyuki Takamatsu

  • Shinsuke Iida

  • Hirono Iriuchishima

  • Shuji Ozaki

  • Karen Tang

  • Jeffrey Huang

  • Jerry Teng

  • Cheng-Shyong Chang

  • Changki Min

  • Wenming Chen

  • Hiroshi Handa

  • Kihyun Kim

  • Priti Bahety

  • Juan Du

  • Wee Joo Chng

  • November 11, 2026

Share

Original Source(s)

Real-world treatment patterns and clinical outcomes in relapsed/refractory multiple myeloma across Asia: a multicenter Asian Myeloma Network study (AMN010)

  • by Melinda SY Tan, Kye Ling Wong, Cinnie Soekojo, Chandramouli Nagarajan, Sarah Burkhill, Xinhua Li, Ho-Jin Shin, Jong Heon Jung, Yeung-Chul Mun, Ho-Young Yhim, Jae Hoon Lee, Ling Cao, Tadao Ishida, Chihiro Shimazaki, Makoto Sasaki, Hiroyuki Takamatsu, Shinsuke Iida, Hirono Iriuchishima, Shuji Ozaki, Karen Tang, Jeffrey Huang, Jerry Teng, Cheng-Shyong Chang, Changki Min, Wenming Chen, Hiroshi Handa, Kihyun Kim, Priti Bahety, Juan Du, Wee Joo Chng

  • November 11, 2026

Related Content

Can Immunopeptidomics Redefine Cancer Immunotherapy Development?

Immunopeptidomics is helping researchers identify tumor-presented antigens that could inform the development of targeted cell therapies and personalized cancer vaccines

Two ‘forever chemicals’ associated with higher risk of aggressive breast cancer in NIH analysis

What Your Patients Need to Know for Medicare Open Enrollment

The annual Medicare open enrollment period runs October 15 to December 7 this year, giving adults ages 65 and older the opportunity to review and possibly change their healthcare coverage.

  • by

  • November 5, 2026

  • 2 min